Updated adult immunization schedule for ages 19 years or older released by CDC

Human Papillomavirus (HPV) Vaccination

• Update to routine vaccination section: No additional doses are recommended for individuals who have completed the HPV vaccine series with any valency using the recommended dosing intervals.

Influenza Vaccination

· note has been added to the Special Situations section stating that persons with an egg allergy can receive any influenza vaccine (egg-based and non-egg-based) appropriate for age and health status.

Meningococcal Vaccination

· Menactra (MenACWY-D) has been removed from all sections.

· Penbraya (meningococcal groups A, B, C, W and Y vaccine) has been added to the schedule for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroups A, B, C, W, and Y in individuals 10 through 25 years of age.

Mpox Vaccination

· Guidance on the use of Jynneos (smallpox and monkeypox vaccine, live, nonreplicating) in adults based on sexual risk factors has been added.

Pneumococcal Vaccination

· Guidance on determining which pneumococcal vaccines a patient needs and the minimum intervals between doses has been revised to provide additional clarity.

Poliovirus Vaccination

· Routine recommendation updated to state that adults who are known or suspected to be unvaccinated or incompletely vaccinated should complete the 3-dose IPV primary series.

· Recommendations for adults who have completed the primary series and are at increased risk for exposure to poliovirus have been included.

Respiratory Syncytial Virus (RSV) Vaccination

· Information added on routine RSV vaccination during pregnancy; Abrysvo is the only RSV vaccine recommended for use during pregnancy.

· Guidance has been added on shared clinical decision-making for individuals aged 60 years or older; Arexvy or Abrysvo may be used.

· Guidance for providers in jurisdictions with RSV seasonality that differs from most of the continental US has been added.

· A note has been included listing the risk factors and medical conditions that increase a patient’s risk for severe RSV disease.

References:

Centers for Disease Control and Prevention. Adult Immunization Schedule by Age. Accessed November 17, 2023. https://www.cdc.gov/vaccines/schedules/hcp/imz/adult.html